United Parcel Service has intensified its focus on prescription drug and specialized medical deliveries, a strategy company leaders say will deliver stronger returns in the second half of the year even as the conflict with Iran clouds the global outlook. The premium healthcare business - which includes handling temperature-sensitive medicines and radioactive treatments - is viewed by the company as more resistant to recessionary pressures than sectors such as retail, housing or manufacturing.
Executives point to the stability of healthcare demand amid a backdrop of inflation, market contractions and the prospect that the U.S.-Israeli conflict with Iran could weaken demand for delivery services. Despite those headwinds, the company reports that the healthcare segment continues to expand.
Margins and revenue mix
UPS and its peers are pursuing complex healthcare logistics because specialized handling commands higher prices and healthier margins. For expensive medicines that require careful, often temperature-controlled transport, margins sit in the mid-to-high-teen percentages. By contrast, e-commerce shipments generate margins in the very low single digits, executives say.
That margin differential has been a central element of the company’s multi-year turnaround as it reduces reliance on large volumes of low-margin parcels and reconfigures its network to prioritize fewer but more profitable deliveries. The strategy is already producing measurable results: UPS reported its first $3 billion healthcare revenue quarter in company history and says it has taken share in the space since 2021.
On an annual basis, the company recorded 2025 healthcare revenue of $11.2 billion, roughly 13% of consolidated revenue. In the first quarter of 2026, healthcare accounted for more than 14% of consolidated revenue.
Market position and competition
Through acquisitions and organic growth the company now dominates the outsourced healthcare logistics market, which it values at more than $80 billion. The firm cites analyst forecasts that this market could more than double over the next decade. Competitors, including FedEx and Germany’s DHL Group, are also targeting growth in this segment.
Vulnerabilities within healthcare
While UPS highlights the recession-resistant nature of healthcare logistics broadly, analysts and company officials identify one part of the business that remains sensitive to consumer spending: home deliveries of GLP-1 weight-loss drugs. Those shipments are paid for directly by consumers rather than insurers, and therefore are more exposed to demand swings in a downturn.
Operational changes and strategy
The company’s current chief executive, an executive recruited from outside the firm in June 2020, has pursued a "better, not bigger" strategy that includes reducing dependence on a single large retail customer and investing in higher-margin services. Under this plan the company has scaled down lighter, value-priced shipments and reallocated resources to expand its healthcare footprint.
As part of the shift, the company has reduced Amazon’s share of its business from a peak of more than 13% to 8.8% in the latest quarter. To offset the loss of millions of low-value retail packages, the company closed facilities and reduced headcount across various parts of the business. Those cuts affected a range of roles, including union delivery drivers who, the company notes, can earn in excess of $100,000 per year.
The firm also handed off its value-priced Ground Saver deliveries to the U.S. Postal Service as U.S. tariff policy reduced the flow of millions of low-value "de minimis" shipments from China-linked merchants.
Technology, automation and cost savings
At the same time, upgrades to hubs with automation, improved package-tracking technology and other efficiency tools are nearing completion. Company officials say those investments should make deliveries more cost-efficient and are already producing savings in operating costs measured in the billions. Stifel analyst Bruce Chan summed up the transformation in a client note titled: "Home Stretch: Heaviest Lift of Transformation Complete ... Now for the Benefits to Materialize." The firm and analysts expect that the bulk of the work is done and that profitability gains will follow as those efficiencies take hold.
Macro pressures
Company leaders report that the core business remains resilient even as fuel prices have risen sharply after the virtual closure of the Strait of Hormuz linked to the Iran conflict. Higher fuel costs are pressuring household and corporate budgets, but the company says underlying demand has held up.
Outlook
With a larger share of revenue now coming from healthcare logistics, the company expects to realize the benefits of its strategic shifts as automation and network reconfiguration finish rolling out. At the same time, management and analysts continue to watch pockets of consumer-paid healthcare deliveries that could soften if a broader economic slowdown develops tied to geopolitical tensions or other factors.